Role of hyperhomocysteinemia in atherosclerosis: from bench to bedside
Background Atherosclerosis is a leading cause of global mortality, driven by complex interactions between genetic, metabolic, and environmental factors. Among these, hyperhomocysteinemia (HHcy) has emerged as a significant and modifiable risk factor, contributing to endothelial dysfunction, oxidativ...
Saved in:
Main Authors: | Wende Tian, Jianqing Ju, Baoyi Guan, Tongxin Wang, Jiqian Zhang, Luxia Song, Hao Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Annals of Medicine |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2025.2457527 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pterostilbene antagonizes homocysteine-induced oxidative stress, apoptosis and lipid deposition in vascular endothelial cells
by: Qiao Jiang, et al.
Published: (2023-09-01) -
Metabolic and epigenetic regulation of macrophage polarization in atherosclerosis: Molecular mechanisms and targeted therapies
by: Pinglian Yang, et al.
Published: (2025-02-01) -
Hyperhomocysteinemia-induced VCID results in visual deficits, reduced neuroinflammation and vascular alterations in the retina
by: Erica M. Weekman, et al.
Published: (2025-01-01) -
Vascular cytoprotection, autoimmune disease, and premature atherosclerosis
by: Justin C Mason
Published: (2018-01-01) -
Annexin A8 deficiency delays atherosclerosis progression
by: Carmen Gutiérrez‐Muñoz, et al.
Published: (2025-01-01)